1 Oct 2026 · 10 min
The risk of colorectal cancer with MASLD
Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Ming-Hua Zheng from the MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, and the Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China, on the paper "Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement" published in paper copy in…












